MEAGAN MURGEL: Open Payments
NPI 1134537707 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,250 in 101 payments from 23 companies in 2025. Trend: 2023 $3,259 · 2024 $2,048 · 2025 $2,250
Food & beverage: $2,250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $830 |
| PFIZER INC. | 18 | $326 |
| Alexion Pharmaceuticals, Inc. | 4 | $192 |
| UCB, Inc. | 4 | $117 |
| EMD Serono, Inc. | 3 | $88 |
| TG Therapeutics, Inc. | 3 | $85 |
| Amgen Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Neurelis, Inc. | 2 | $65 |
| SpringWorks Therapeutics, Inc. | 2 | $49 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, BOTOX, KOSELUGO, PANZYGA, BRIUMVI, VYALEV.
Industry payments across CO — which companies pay providers there.
